Meta AnalysisID 5648
安宫牛黄丸辅助治疗卒中疗效的Meta分析
CRD42022314931
In this meta-analysis, the clinical but relatively common stroke patients were selected. These include hemorrhagic stroke, ischemic stroke, and the stages include acute and chronic patients; on the premise that the disea
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 5648
- Evidence Id
- 14206
- Core Evidence Id
- 14206
- Source Meta Analysis Id
- 5630
- Herb2 Meta Analysis Id
- HBMA005630
- Crd Id
- CRD42022314931
- Title
- Meta-analysis of the efficacy of Angong Niuhuang Pill in adjuvant treatment of stroke
- Review Question
- In this meta-analysis, the clinical but relatively common stroke patients were selected. These include hemorrhagic stroke, ischemic stroke, and the stages include acute and chronic patients; on the premise that the disease meets the diagnosis and treatment standards, the selected research plan is to use Angong Niuhuang Pill as the intervention measure combined with conventional treatment. Research protocol for controlled experiments.
- Study Type Included
- According to the established criteria for selecting literature, find clinical observation articles based on randomized controlled trials in the data section.
- Condition Being Studied
- Stroke is an acute cerebrovascular disease caused by cerebral blood supply disorder, which has the characteristics of high morbidity, high disability and high mortality. Mainly divided into hemorrhagic and ischemic stroke. Among them, ischemic stroke accounts for 75% to 85% of the total number of stroke patients, but hemorrhagic stroke brings more serious mortality and disability. Stroke seriously affects the quality of life of patients and increases the burden on families.
- Participant
- Patients with acute or chronic stroke who meet the diagnostic criteria of traditional Chinese medicine and Western medicine, and the age and gender of the patients are not limited.
- Animal
- Human Disease Modelled
- Intervention
- The intervention is Angong Niuhuang Pill
- Comparator Control
- Controls included conventional therapy or placebo for acute or chronic stroke.
- Main Outcome
- The selected outcome indicators included survival rate, mortality, neurological score, Glasgow Coma Index score, length of hospital stay, inflammatory indicators, cerebral infarction area and cerebral hemorrhage area. Measures of effect RR
- Outcome Measure
- Additional Outcome
- Study Method
- Systematic review
- Keyword
- Angong Niuhuang Pill; Drug Combinations; Drugs, Chinese Herbal; Humans; Stroke
- Contact
- GUO JunLi [email protected]
- Organisational Affiliation
- Graduate School of Hebei University of Traditional Chinese Medicine.
- Funding Source
- Hebei University of Traditional Chinese Medicine: KTZ201902
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- Chinese-Simplified, English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2022-03-05
- Registration Date
- 2022-04-05
- Anticipated Start Date
- 2022-03-09
- Anticipated Completion Date
- 2022-07-31
- Title Cn
- 安宫牛黄丸辅助治疗卒中疗效的Meta分析
- Title En
- Meta-analysis of the efficacy of Angong Niuhuang Pill in adjuvant treatment of stroke
- Bilingual Status
- complete